| scholarly article | Q13442814 |
| P2093 | author name string | Indhu Hariharan | |
| Jem Prabhakar | |||
| Hima Sithul | |||
| Sreeja Sreekumar | |||
| Juberiya M Azeez | |||
| Madhavan Radhakrishna Pillai | |||
| Sreeharshan Sreeja | |||
| P2860 | cites work | Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 |
| Molecular determinants of context-dependent progesterone receptor action in breast cancer | Q26997928 | ||
| PTEN regulation of ERK1/2 signaling in cancer | Q27011088 | ||
| PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms | Q28181035 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis | Q33538451 | ||
| Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1). | Q33567280 | ||
| Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression | Q33595229 | ||
| Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals | Q33668753 | ||
| SOD1, an unexpected novel target for cancer therapy | Q33776847 | ||
| Estrogen and progestin regulation of cell cycle progression | Q33923687 | ||
| Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis | Q34371260 | ||
| Impact of oestradiol and progesterone on antioxidant activity in normal human breast epithelial cells in culture. | Q50872641 | ||
| Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. | Q52180037 | ||
| Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle1 | Q60662131 | ||
| Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential | Q68097526 | ||
| Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer | Q68299182 | ||
| PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2) | Q73617626 | ||
| PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation | Q78026206 | ||
| Estrogen and oxidative stress | Q80512214 | ||
| Breast cancer--loss of PTEN predicts resistance to treatment | Q81059127 | ||
| Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer | Q94158597 | ||
| Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast | Q35788322 | ||
| Estrous influence on surgical cure of a mouse breast cancer | Q36355139 | ||
| Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension | Q36921506 | ||
| Reactive oxygen species in cancer | Q37431048 | ||
| Progestin regulation of cellular proliferation | Q37818260 | ||
| The role of surgery in metastatic breast cancer | Q37937931 | ||
| Endocrine treatment of breast cancer in women | Q37938852 | ||
| Tumor suppressor genes and ROS: complex networks of interactions | Q37948470 | ||
| The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. | Q39344606 | ||
| Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species | Q39617962 | ||
| TOB suppresses breast cancer tumorigenesis | Q39830658 | ||
| Mechanisms of hormone resistance in breast cancer | Q40770822 | ||
| Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways | Q40995230 | ||
| Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). | Q41084288 | ||
| Timing of Breast Cancer Excision during the Menstrual Cycle Influences Duration of Disease-free Survival | Q41157197 | ||
| Menstrual influence on surgical cure of breast cancer | Q41218759 | ||
| Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. | Q42454022 | ||
| Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer | Q43675669 | ||
| The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years? | Q43976265 | ||
| Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer | Q43976269 | ||
| Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium | Q44787029 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5987-5999 | |
| P577 | publication date | 2015-11-09 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence | |
| P478 | volume | 9 |
| Q47891451 | Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells |
| Q52669327 | Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression. |
| Q37267043 | Progesterone influences cytoplasmic maturation in porcine oocytes developing in vitro. |
| Q58597684 | Up-regulation of the kinase gene by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells |
Search more.